Kevin J. Stumbo, EVP, CFO & Treasurer of Community Trust Bancorp Inc., filed a Form 4 disclosing the sale of 50 shares of company common stock on December 19, 2025. The transaction was executed at $58.73 per share, resulting in total proceeds of approximately $2,936.50. Following this sale, Stumbo directly holds 5,908....

On December 19, 2025, Kenneth D. Denman, a director at Costco Wholesale Corp, reported a disposition of 325 shares of Common Stock. The transaction, coded as a gift (G) with a transaction price of $0.00, resulted in a post-transaction ownership of 5663.936 shares. The gift was made to a charitable donor-advised fund, a...

This filing details Form 4 transactions for COTY INC., filed on October 19, 2025. Reporting owner Zafar Ayesha, SVP Group Controller, acquired shares through Restricted Stock Units (RSUs). The first transaction involved 23,787 RSUs, settling into Class A common stock, with vesting expected on October 19, 2028. The seco...

This filing details a transaction by Anna von Bayern, Chief Corp. Affairs Officer of Coty Inc. On December 22, 2025, Ms. von Bayern acquired 61,050 Restricted Stock Units (RSUs) with a reported transaction price of $0.00. These RSUs are set to vest on October 19, 2028, and upon vesting, each RSU will settle for one sha...

This filing details a Form 4 submission for COTY INC. (COTY) concerning transactions by Laurent Mercier, Chief Financial Officer. On December 22, 2025, Mercier acquired 111,925 Restricted Stock Units (RSUs) of Class A common stock. These RSUs have a reported price of $0.00 and are subject to vesting conditions, with se...

This filing details stock transactions by Priya Srinivasan, Chief People & Purpose Officer of COTY INC. On December 22, 2025, Srinivasan acquired 81,846 Restricted Stock Units (RSUs) and 66,964 RSUs, which settle for Class A common stock. These RSUs are subject to vesting conditions, with portions vesting on October 19...

This filing details a transaction by Samarth Kulkarni, Chief Executive Officer and Director of CRISPR Therapeutics AG (CRSP). On December 18, 2025, Mr. Kulkarni disposed of 30,000 common shares with a transaction price of $0.00 per share. This transaction was coded as 'G' (likely indicating a gift or grant) and resulte...

This filing details a transaction by Kevin Cronin, a director at CROSS COUNTRY HEALTHCARE INC (CCRN). On December 18, 2025, Mr. Cronin acquired 162,672 shares of Common Stock through a grant of restricted stock units (RSUs). These RSUs vest in three equal installments on December 18, 2026, March 31, 2027, and March 31,...

Cynthia Ann Grieco, VP, Corporate Treasurer at CROSS COUNTRY HEALTHCARE INC, was granted 11,288 restricted shares of common stock on December 18, 2025. These shares vest in three equal installments on December 18, 2026, March 31, 2027, and March 31, 2028. The grant date was moved to December 18, 2025, from March 31, 20...

This filing details a transaction by Marc S. Krug, Group President, Delivery at CROSS COUNTRY HEALTHCARE INC. On December 18, 2025, Mr. Krug acquired 23,817 shares of common stock under a restricted stock award (RSA) program. These RSAs vest in three equal installments on December 18, 2026, March 31, 2027, and March 31...

Colin Patrick McDonald, Chief Human Resources Officer of CROSS COUNTRY HEALTHCARE INC, reported a transaction on December 18, 2025. The filing indicates the acquisition of 9,340 restricted shares of common stock (RSAs) with a transaction price of $0.0 per share. These RSAs vest in three equal installments on December 1...

Karen Mote, President of Cross Country Locums at CROSS COUNTRY HEALTHCARE INC (CCRN), was granted 8,095 restricted stock awards (RSAs) on December 18, 2025. These RSAs vest in three equal installments on December 18, 2026, March 31, 2027, and March 31, 2028. The grant, approved after the termination of a merger agreeme...

Phillip L. Noe, Chief Information Officer of CROSS COUNTRY HEALTHCARE INC (CCRN), acquired 12,826 shares of common stock on December 18, 2025. The acquisition was part of a grant of restricted stock awards (RSAs) that vest in three equal installments on December 18, 2026, March 31, 2027, and March 31, 2028. This grant ...

This filing details a grant of 12,311 restricted stock units (RSUs) to James V. Redd III, Chief Accounting Officer of CROSS COUNTRY HEALTHCARE INC (CCRN), on December 18, 2025. These RSUs vest in three equal installments on December 18, 2026, March 31, 2027, and March 31, 2028. The grant was approved following the term...

Gale S. Fitzgerald, a director at CROSS COUNTRY HEALTHCARE INC (CCRN), reported a transaction on December 18, 2025. Fitzgerald acquired 18,680 restricted shares of common stock (RSAs) with a transaction price of $0.0. These RSAs are set to vest on December 18, 2025. The Compensation Committee approved the grant of thes...

This filing details a transaction by Janice Elizabeth Nevin, a director at CROSS COUNTRY HEALTHCARE INC (CCRN). On December 18, 2025, Nevin acquired 18,680 shares of Common Stock with a transaction price of $0.0. This acquisition was part of restricted stock units (RSAs) that will vest on December 18, 2025. The Compens...

This filing details significant insider transactions for COGNITION THERAPEUTICS INC (CGTX) on December 18, 2025. Anthony Caggiano, Chief Medical Officer, acquired 65,000 shares of Common Stock through the vesting of performance stock units (PSUs) with no price per share, increasing his holdings to 528,273 shares. In a ...

This filing details a transaction by Michelle Wirfel, EVP, Chief Operating Officer of California BanCorp (BCAL), on December 21, 2025. Ms. Wirfel disposed of 93 shares of common stock at a price of $19.50 per share, resulting in 76,692 shares held post-transaction. The disposition was made to cover tax liabilities aris...

Yuri Maricich, Chief Medical Officer of Camp4 Therapeutics Corp, was granted 190,000 stock options on December 11, 2025. The options have an exercise price of $6.01 and an expiration date of December 10, 2035. The options vest starting December 1, 2025, with one-third vesting on the first anniversary and the remainder ...

This filing details a Form 4 filed by Josh Mandel-Brehm, Chief Executive Officer and Director of Camp4 Therapeutics Corp. On December 11, 2025, Mandel-Brehm acquired 425,000 stock options with a right to buy common stock. These options have an exercise price of $6.01 and an expiration date of December 10, 2035. The opt...

This filing details a Form 4 submission for Camp4 Therapeutics Corp, reporting on a stock option grant to Chief Financial Officer Kelly Gold. The transaction, dated December 11, 2025, involved the acquisition of 190,000 stock options with a right to buy common stock at a price of $0.00. The options have a post-transact...

Daniel Tardiff, Chief Scientific Officer of Camp4 Therapeutics Corp, was granted 145,500 stock options on December 11, 2025. These options, with an exercise price of $6.01, allow for the purchase of common stock. The options have an exercise date that is subject to footnote F1, indicating a vesting schedule that begins...

Kathy Yamada, EVP & Chief Credit Officer of Capital Bancorp Inc, reported a transaction on December 19, 2025. She acquired 6,900 shares of common stock at $13.89 per share and disposed of 3,545 shares at $29.64 per share. Following these transactions, her post-transaction shares of common stock are 60,865. Additionally...

This filing details transactions made by John D. Idol, Chairman & CEO of Capri Holdings Ltd. On December 19, 2025, Mr. Idol acquired 13,164 ordinary shares with a transaction value of $0.00, which were designated as vested restricted share units (RSUs) converted to cover tax withholding obligations. The post-transactio...

This Form 4 filing details a transaction by Jay O. Wright, EVP - Strategy and General Counsel, Secretary of Castellum, Inc. On December 19, 2025, Mr. Wright disposed of 30,000 shares of Common Stock at a price of $1.05 per share. Following this transaction, Mr. Wright directly owns 7,134,973 shares of Castellum, Inc. C...